INSIGHT BIOPHARMA CONSULTANCY LIMITED
FORSHAWS ACCOUNTANTS CROSSENS WAY BUSINESS PARK, CROSSENS WAY, SOUTHPORT  PR9 9LY- Active
- Private Limited Company
- Company No. 14900627
- Last Updated: 01 Mar 2024
Company Profile
INSIGHT BIOPHARMA CONSULTANCY LIMITED was incorporated on Monday, May 29, 2023 as a Private Limited Company with registered address in SOUTHPORT. INSIGHT BIOPHARMA CONSULTANCY LIMITED has the status: Active and it's listed in the following category: Other professional, scientific and technical activities n.e.c.. This Private Limited Company has been operating for 1 year 3 months and 22 days.
Name | INSIGHT BIOPHARMA CONSULTANCY LIMITED |
---|---|
Company number | 14900627 |
Company type | Private Limited Company |
Incorporation date | 29 May 2023 |
Status | Active |
Industry (SIC 2007) |
Address
Registered Address |
FORSHAWS ACCOUNTANTS CROSSENS WAY BUSINESS PARK CROSSENS WAY SOUTHPORT PR9 9LY |
---|---|
Country Of Origin | UNITED KINGDOM |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Mrs Margaret Nelligan Nationality: British |
Dates: Monday, May 29, 2023 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
|
Dr Ian Nelligan Nationality: British |
Dates: Monday, May 29, 2023 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
right to appoint and remove directors
|
Accounts and Confirmation
Type of accounts | NO ACCOUNTS FILED |
---|---|
End of financial Year | 31 May |
Next annual accounts due | 28 February 2025, (160 days left) |
Latest accounts | Not available |
Next confirmation statement due | 26 June 2024 |
Last confirmation statement dated | Not available |
Mortgages
No mortgages have been registered against INSIGHT BIOPHARMA CONSULTANCY LIMITED.
Previous Names
Name | Change Date |
---|---|
INSIGHT BIOPHARMA CONSULTANCY LIMITED | 29 May 2023 |